Low Expression Levels of miRNA-155 and miRNA-499a are Associated with Obesity in Type 2 Diabetes

References

• Pillon NJ , Loos RJF , Marshall SM , Zierath JR . Metabolic consequences of obesity and Type 2 diabetes: balancing genes and environment for personalized care. Cell 184(6), 1530–1544 (2021).
   PubMed Web of Science ®Google Scholar
• Lee JJ , Beretvas SN , Freeland-Graves JH . Abdominal adiposity distribution in diabetic/prediabetic and nondiabetic populations: a meta-analysis. J. Obes. 2014, 697264 (2014).
   PubMedGoogle Scholar
• Landrier JF , Derghal A , Mounien L . MicroRNAs in obesity and related metabolic disorders. Cells 8(8), 859 (2019).
   PubMed Web of Science ®Google Scholar
• O’Brien J , Hayder H , Zayed Y , Peng C . Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. (Lausanne) 9, 402 (2018).
   PubMed Web of Science ®Google Scholar
• Kim M , Zhang X . The profiling and role of miRNAs in diabetes mellitus. J. Diabetes Clin. Res. 1(1), 5–23 (2019).
   PubMedGoogle Scholar
• Ciccacci C , Latini A , Colantuono A et al. Expression study of candidate miRNAs and evaluation of their potential use as biomarkers of diabetic neuropathy. Epigenomics 12(7), 575–585 (2020).
   PubMed Web of Science ®Google Scholar
• Mahesh G , Biswas R . MicroRNA-155: a master regulator of inflammation. J. Interferon Cytokine Res. 39(6), 321–330 (2019).
   PubMed Web of Science ®Google Scholar
• Yang P , Han J , Li S , Luo S , Tu X , Ye Z . miR-128-3p inhibits apoptosis and inflammation in LPS-induced sepsis by targeting TGFBR2. Open Med. (Wars.) 16(1), 274–283 (2021).
   PubMedGoogle Scholar
• Wan Q , Xu T , Ding W et al. miR-499-5p attenuates mitochondrial fission and cell apoptosis via p21 in doxorubicin cardiotoxicity. Front. Genet. 9, 734 (2019).
   PubMed Web of Science ®Google Scholar
• Chen C , Deng Y , Hu X et al. miR-128-3p regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2. J. Physiol. Biochem. 74(3), 381–393 (2018).
   PubMed Web of Science ®Google Scholar
• Wang L , Zhang N , Wang Z , Ai DM , Cao ZY , Pan HP . Decreased miR-155 level in the peripheral blood of non-alcoholic fatty liver disease patients may serve as a biomarker and may influence LXR activity. Cell Physiol. Biochem. 39(6), 2239–2248 (2016).
   PubMedGoogle Scholar
• Smith AG , Singleton JR . Diabetic neuropathy. Continuum 18(1), 60–84 (2012).
   PubMedGoogle Scholar
• Tesfaye S , Chaturvedi N , Eaton SE et al. Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 352(4), 341–350 (2005).
   PubMed Web of Science ®Google Scholar
• Gabir MM , Hanson RL , Dabelea D et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23(8), 1108–1112 (2000).
   PubMed Web of Science ®Google Scholar
• Lodhi IJ , Semenkovich CF . Peroxisomes: a nexus for lipid metabolism and cellular signaling. Cell Metab. 19(3), 380–392 (2014).
   PubMed Web of Science ®Google Scholar
• Hallenborg P , Jensen BAH , Fjære E et al. Adipose MDM2 regulates systemic insulin sensitivity. Sci. Rep. 11(1), 21839 (2021).
   PubMed Web of Science ®Google Scholar
• Tryggestad JB , Teague AM , Sparling DP , Jiang S , Chernausek SD . Macrophage-derived microRNA-155 increases in obesity and influences adipocyte metabolism by targeting peroxisome proliferator-activated receptor gamma. Obesity (Silver Spring) 27(11), 1856–1864 (2019).
   PubMed Web of Science ®Google Scholar
• Mahdavi R , Ghorbani S , Alipoor B et al. Decreased serum level of miR-155 is associated with obesity and its related metabolic traits. Clin. Lab. 64(1), 77–84 (2018).
   PubMed Web of Science ®Google Scholar
• Cerda A , Amaral AA , de Oliveira R et al. Peripheral blood miRome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients. Int. J. Mol. Sci. 22(3), 1468 (2021).
   PubMed Web of Science ®Google Scholar
• Lin X , Qin Y , Jia J et al. miR-155 enhances insulin sensitivity by coordinated regulation of multiple genes in mice. PLOS Genet. 12, e1006308 (2016).
   PubMed Web of Science ®Google Scholar
• Latini A , Spallone V , D’Amato C , Novelli G , Borgiani P , Ciccacci C . A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop Type 2 diabetes. Acta Diabetol. 56(6), 717–718 (2019).
   PubMed Web of Science ®Google Scholar
• Xie K , Ma H , Liang C et al. A functional variant in miR-155 regulation region contributes to lung cancer risk and survival. Oncotarget 6, 42781–42792 (2015).
   PubMedGoogle Scholar
• Deddens JC , Colijn JM , Oerlemans MI et al. Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. J. Cardiovasc. Transl. Res. 6(6), 884–898 (2013).
   PubMed Web of Science ®Google Scholar
• Giuliani A , Montesanto A , Matacchione G et al. The association between single nucleotide polymorphisms, including miR-499a genetic variants, and dyslipidemia in subjects treated with pharmacological or phytochemical lipid-lowering agents. Int. J. Mol. Sci. 23(10), 5617 (2022).
   PubMed Web of Science ®Google Scholar
• Chen LB , Zheng HK , Zhang L et al. A single nucleotide polymorphism located in microRNA-499a causes loss of function resulting in increased expression of osbpl1a and reduced serum HDL level. Oncol. Rep. 38(6), 3515–3521 (2017).
   PubMed Web of Science ®Google Scholar
• Wang JX , Jiao JQ , Li Q et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med. 17(1), 71–78 (2011).
   PubMed Web of Science ®Google Scholar
• Afshinnia F , Reynolds EL , Rajendiran TM et al. Serum lipidomic determinants of human diabetic neuropathy in Type 2 diabetes. Ann. Clin. Transl. Neurol. 9(9), 1392–1404 (2022).
   PubMed Web of Science ®Google Scholar
• Elafros MA , Andersen H , Bennett DL et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol. 21(10), 922–936 (2022).
   PubMed Web of Science ®Google Scholar
• Spallone V , Ciccacci C , Latini A , Borgiani P . What is in the field for genetics and epigenetics of diabetic neuropathy: the role of microRNAs. J. Diabetes Res. 2021, 5593608 (2021).
   PubMed Web of Science ®Google Scholar